Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1942 of 6351
-
Meal timing may ease cancer therapy woes
Symptom relief Recruiting nowThe purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New antibody HX009 shows promise for tough lymphoma cases
Disease control CompletedThis study is a multi-center, open, single-arm phase I/II clinical study to evaluate the recombinant humanized anti-CD47/PD-1 bifunctional antibody HX009 injection in Chinese patients with relapsed/refractory lymphoma .
Phase 1/2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Myeloma patients may soon ditch daily pills if cancer stays hidden
Disease control Recruiting nowA pilot study to assess the risk of progression after stopping post-autologous stem cell transplant (ASCT) maintenance therapy in Minimal Residual Disease (MRD)-negative MM patients.
Phase 1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedStudy BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of vamikibart administered intravitreally in participants with diabetic macular edema.…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to cut Blood-Letting in rare blood cancer
Disease control CompletedThe main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments in participants with polycythemia vera.
Phase 2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New glasses could help kids see better longer
Disease control CompletedThe purpose of this study is to demonstrate that the test spectacle lens is safe and effective in slowing myopia progression in children.
Sponsor: Essilor International • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug shows promise for Hard-to-Treat lung condition in heart failure
Disease control CompletedThis is a Phase 2, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of sotatercept versus placebo in adults with Cpc-PH due to HFpEF. The objective of this study is to evaluate the efficacy, safety and tolerability of sotatercept versus plac…
Phase 2 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New therapy aims to ease PTSD in new moms after traumatic birth
Symptom relief CompletedThe aim of this study is to assess if an early therapeutic management focused on the mother-baby interaction using Interaction Guidance Therapy (IGT) with video feedback, brings an improvement of the maternal sensitivity in the interaction but also a decrease of the post-traumati…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for hidradenitis sufferers: experimental drug lutikizumab enters phase 2 trial
Disease control OngoingHidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. Despite the clinical benefit anti-tumor…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radiation after thymoma surgery: does it keep cancer away?
Disease control Recruiting nowThe primary objective of the study : to compare the Recurrence-Free survival (RFS) between arms. RFS is defined as time from randomisation to the first recurrence (either local-regional or distant) or death of any cause.
Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New immune therapy aims to train body to attack rectal cancer cells
Disease control OngoingConducting an early phase clinical trial to assess CEA Antigen Presentation Therapeutic Biological Product Mix activity that suggests the potential for clinical benefit of CEA positive rectal cancer patients. 1. Treat CEA positive rectal cancer via Trained Immunity. 2. Activate …
Phase 1 • Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can a phone app boost HIV prevention in thai youth?
Prevention CompletedThe main aim of this study is to develop technology-based interventions to improve HIV pre-exposure prophylaxis (PrEP) uptake and adherence among Thai young transgender women.
Sponsor: University of Massachusetts, Worcester • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Precision radiation may slow rare salivary gland cancer
Disease control Recruiting nowThe aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a rheumatoid arthritis drug tame CAR-T's worst side effects?
Disease control CompletedThis phase II trial studies how well anakinra works in decreasing the occurrence of cytokine release syndrome (CRS) and damage to the nerves (neurotoxicity) in patients with B-cell non-Hodgkin lymphoma who are receiving CD-19 targeted chimeric antigen receptor T-cell (CAR-T) ther…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Opioid-Free pain relief after thumb surgery shows promise in new study
Symptom relief Recruiting nowIn the US, pain management after surgery for surgical treatment of osteoarthritis at the base of the thumb typically consists of prescription opioids during the early recovery phase. Given the highly addictive nature of prescription opioids, guidelines are being evaluated by hand…
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
Could stem cells ease autism symptoms? new trial tests combo therapy
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow mononuclear cell infusion combined with educational intervention for children with autism spectrum disorder (ASD). Inclusion criteria: Male/Female patients diagnosed with Autism disord…
Phase 2 • Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
VR therapy helps teens with anorexia overcome body fears
Symptom relief CompletedAnorexia Nervosa (AN) is considered one of the most severe subtypes of eating disorders (EDs), characterized by significant medical complications, high mortality rates, and high comorbidity with other disorders, such as anxiety disorders. Similarly to what occurs in anxiety disor…
Sponsor: University of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can routine brain scans catch hidden cancer spread in stage IV breast cancer?
Diagnosis Recruiting nowThe study is a single arm, nonrandomized phase II prospective study, with the goal of investigating the role of screening brain MRIs in neurologically asymptomatic patients with metastatic breast cancer.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
New drug shows promise for Hard-to-Treat blood cancer
Disease control CompletedThe purpose of this study is to understand the study medicine (called Elranatamab, or PF-06863135) as potential treatment for refractory multiple myeloma. Multiple myeloma is a form of cancer in the bone that forces healthy blood cells to go out. Sometimes, multiple myeloma does …
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a conversation after childbirth shape a Mother's contraceptive choices?
Prevention CompletedThe purpose of this study is to evaluate the effect of contraceptive method counseling offered to primiparous women between the ages of 18-45 in the postpartum period by motivational interviewing method based on the Transtheoretic model, on the use of contraceptive methods.
Sponsor: Istanbul University - Cerrahpasa • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC